The animal drug compounding market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to regulatory landscape, veterinary practices, market awareness, limited commercial options, veterinary collaboration.
The animal drug compounding market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to regulatory developments, pet ownership trends, specialized veterinary care, globalization of veterinary services, advancements in veterinary medicine. Major trends in the forecast period include focus on flavoring and palatability, demand for specialized dosage forms, collaboration between veterinarians and compounding pharmacists, focus on pain management solutions, growing role in veterinary hospice care.
An increase in the rate of animal adoption is anticipated to boost the growth of the animal drug compounding market in the future. Animal adoption refers to acquiring pets through rescue organizations rather than purchasing them from pet stores or breeders. Adopted animals often come with pre-existing health issues or may require medications that are not available in standard formulations, leading to a higher demand for customized medications for these animals. As more pet owners seek tailored medications for their adopted pets, the necessity for animal drug compounding rises. For example, in October 2023, Novuna, a UK-based financial services company, reported that approximately 10,070 dogs were adopted, marking an 11.06% increase compared to 2022. Consequently, the rise in animal adoption rates is driving the growth of the animal drug compounding market.
Increasing pet expenditure is expected to further propel the growth of the animal drug compounding market. Pet expenditure encompasses the total amount spent on various aspects of pet ownership and care. This spending contributes to the demand for tailored medications that address the unique needs of individual animals, thereby encouraging compounding pharmacies to continue offering these specialized services in veterinary care. For instance, in October 2023, the North American Pet Health Insurance Association (NAPHIA), a US-based trade organization, stated that in 2022, pet owners in the United States spent $136.8 billion on their dogs, cats, birds, and other companion animals, with this figure projected to increase to $143.6 billion in 2023. Therefore, the rising pet expenditure is driving the growth of the animal drug compounding market.
Major companies in the animal drug compounding market are creating innovative products, such as feline-friendly formulations, to improve the safety and effectiveness of medications specifically designed for cats. Feline-friendly formulations are products tailored to be safe, effective, and appealing to cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company, launched compounded molnupiravir. This antiviral medication is specifically formulated to treat Feline Infectious Peritonitis (FIP) in cats. Wedgewood offers various dosages of feline-friendly molnupiravir to address different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This includes producing a range of dosages and flavors, such as flavored oral oil suspensions and capsules, to cater to the unique needs of individual feline patients.
Leading entities within the animal drug compounding market are actively engaging in partnerships to bolster their revenues and market positioning. Brava, a tech-driven network of compounding pharmacies, collaborates with veterinarians, offering innovative tools, expert pharmacy support, and exceptional customer care. In October 2022, Veterinary Growth Partners, a prominent US-based veterinary services organization representing over 6,000 veterinary practices, designated Brava as its preferred veterinary compounding pharmacy provider. This partnership strives to enhance personalized care in veterinary compounding, streamline processes to ensure regulatory compliance, and deliver top-notch compounding pharmacy solutions.
In May 2024, MixLab, a US-based pharmaceutical laboratory, acquired Nexgen Animal Health for an undisclosed amount. This acquisition aims to expand MixLab's veterinary compounding services to include large animals while enhancing the pharmacy experience through advanced technology and increased capacity. Nexgen Animal Health, also based in the US, specializes in formulating innovative products and drug compounds for animals.
Major companies operating in the animal drug compounding market include Wedgewood Pharmacy LLC, Triangle Compounding Pharmacy Inc., Davis Islands Pharmacy & Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South LLC, Wellness Compounding Pharmacy of Cary LLC, Miller's Pharmacy, Caringbah Compounding Pharmacy Pty. Ltd., Smith Drug and Compounding Inc., Specialist Compounding Pharmacy Pte Ltd., Tache Pharmacy & Medical Supplies, Hoye's Pharmacy, Vertisis Custom Pharmacy LLC, Smith-Caldwell Drug Store Inc., Sixth Avenue Medical Pharmacy, Pharmaca Integrative Pharmacy Inc., Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., Roadrunner Pharmacy, Medisca Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Diamondback Drugs, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetMed Express Inc., PetRx2Go, South Wellness Pharmacy.
North America was the largest region in the animal drug compounding market in 2024. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal drug compounding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Animal drug compounding involves the process of customizing and altering the ingredients of multiple medicines to create a personalized medication suitable for the specific needs of individual animals or groups of animals. This practice is crucial in veterinary medicine for providing tailored medical treatment to animals.
The primary products of animal drug compounding include anti-infective agents, anti-inflammatory agents, hormones and substitutes, central nervous system (CNS) agents, and other specialized products. Anti-infective agents encompass medications such as antibiotics, antivirals, and antifungals, used to prevent and treat various infections in animals. These agents play a vital role in eliminating infectious germs and controlling the spread of infections among animals. Animal drug compounding is applicable to various types of animals, including companion animals and livestock, and can be administered through different routes such as oral, injectable, topical, among others. This practice is commonly employed in veterinary hospitals, clinics, and diagnostic centers dedicated to veterinary care.
The animal drug compounding market research report is one of a series of new reports that provides animal drug compounding market statistics, including animal drug compounding industry global market size, regional shares, competitors with an animal drug compounding market share, detailed animal drug compounding market segments, market trends and opportunities, and any further data you may need to thrive in the animal drug compounding industry. This animal drug compounding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The animal drug compounding market consists of sales of flavored medications, suppositories, and ophthalmic preparations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The animal drug compounding market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to regulatory developments, pet ownership trends, specialized veterinary care, globalization of veterinary services, advancements in veterinary medicine. Major trends in the forecast period include focus on flavoring and palatability, demand for specialized dosage forms, collaboration between veterinarians and compounding pharmacists, focus on pain management solutions, growing role in veterinary hospice care.
An increase in the rate of animal adoption is anticipated to boost the growth of the animal drug compounding market in the future. Animal adoption refers to acquiring pets through rescue organizations rather than purchasing them from pet stores or breeders. Adopted animals often come with pre-existing health issues or may require medications that are not available in standard formulations, leading to a higher demand for customized medications for these animals. As more pet owners seek tailored medications for their adopted pets, the necessity for animal drug compounding rises. For example, in October 2023, Novuna, a UK-based financial services company, reported that approximately 10,070 dogs were adopted, marking an 11.06% increase compared to 2022. Consequently, the rise in animal adoption rates is driving the growth of the animal drug compounding market.
Increasing pet expenditure is expected to further propel the growth of the animal drug compounding market. Pet expenditure encompasses the total amount spent on various aspects of pet ownership and care. This spending contributes to the demand for tailored medications that address the unique needs of individual animals, thereby encouraging compounding pharmacies to continue offering these specialized services in veterinary care. For instance, in October 2023, the North American Pet Health Insurance Association (NAPHIA), a US-based trade organization, stated that in 2022, pet owners in the United States spent $136.8 billion on their dogs, cats, birds, and other companion animals, with this figure projected to increase to $143.6 billion in 2023. Therefore, the rising pet expenditure is driving the growth of the animal drug compounding market.
Major companies in the animal drug compounding market are creating innovative products, such as feline-friendly formulations, to improve the safety and effectiveness of medications specifically designed for cats. Feline-friendly formulations are products tailored to be safe, effective, and appealing to cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company, launched compounded molnupiravir. This antiviral medication is specifically formulated to treat Feline Infectious Peritonitis (FIP) in cats. Wedgewood offers various dosages of feline-friendly molnupiravir to address different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This includes producing a range of dosages and flavors, such as flavored oral oil suspensions and capsules, to cater to the unique needs of individual feline patients.
Leading entities within the animal drug compounding market are actively engaging in partnerships to bolster their revenues and market positioning. Brava, a tech-driven network of compounding pharmacies, collaborates with veterinarians, offering innovative tools, expert pharmacy support, and exceptional customer care. In October 2022, Veterinary Growth Partners, a prominent US-based veterinary services organization representing over 6,000 veterinary practices, designated Brava as its preferred veterinary compounding pharmacy provider. This partnership strives to enhance personalized care in veterinary compounding, streamline processes to ensure regulatory compliance, and deliver top-notch compounding pharmacy solutions.
In May 2024, MixLab, a US-based pharmaceutical laboratory, acquired Nexgen Animal Health for an undisclosed amount. This acquisition aims to expand MixLab's veterinary compounding services to include large animals while enhancing the pharmacy experience through advanced technology and increased capacity. Nexgen Animal Health, also based in the US, specializes in formulating innovative products and drug compounds for animals.
Major companies operating in the animal drug compounding market include Wedgewood Pharmacy LLC, Triangle Compounding Pharmacy Inc., Davis Islands Pharmacy & Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South LLC, Wellness Compounding Pharmacy of Cary LLC, Miller's Pharmacy, Caringbah Compounding Pharmacy Pty. Ltd., Smith Drug and Compounding Inc., Specialist Compounding Pharmacy Pte Ltd., Tache Pharmacy & Medical Supplies, Hoye's Pharmacy, Vertisis Custom Pharmacy LLC, Smith-Caldwell Drug Store Inc., Sixth Avenue Medical Pharmacy, Pharmaca Integrative Pharmacy Inc., Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., Roadrunner Pharmacy, Medisca Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Diamondback Drugs, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetMed Express Inc., PetRx2Go, South Wellness Pharmacy.
North America was the largest region in the animal drug compounding market in 2024. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal drug compounding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Animal drug compounding involves the process of customizing and altering the ingredients of multiple medicines to create a personalized medication suitable for the specific needs of individual animals or groups of animals. This practice is crucial in veterinary medicine for providing tailored medical treatment to animals.
The primary products of animal drug compounding include anti-infective agents, anti-inflammatory agents, hormones and substitutes, central nervous system (CNS) agents, and other specialized products. Anti-infective agents encompass medications such as antibiotics, antivirals, and antifungals, used to prevent and treat various infections in animals. These agents play a vital role in eliminating infectious germs and controlling the spread of infections among animals. Animal drug compounding is applicable to various types of animals, including companion animals and livestock, and can be administered through different routes such as oral, injectable, topical, among others. This practice is commonly employed in veterinary hospitals, clinics, and diagnostic centers dedicated to veterinary care.
The animal drug compounding market research report is one of a series of new reports that provides animal drug compounding market statistics, including animal drug compounding industry global market size, regional shares, competitors with an animal drug compounding market share, detailed animal drug compounding market segments, market trends and opportunities, and any further data you may need to thrive in the animal drug compounding industry. This animal drug compounding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The animal drug compounding market consists of sales of flavored medications, suppositories, and ophthalmic preparations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Animal Drug Compounding Market Characteristics3. Animal Drug Compounding Market Trends and Strategies4. Animal Drug Compounding Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Animal Drug Compounding Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Animal Drug Compounding Market34. Recent Developments in the Animal Drug Compounding Market
5. Global Animal Drug Compounding Growth Analysis and Strategic Analysis Framework
6. Animal Drug Compounding Market Segmentation
7. Animal Drug Compounding Market Regional and Country Analysis
8. Asia-Pacific Animal Drug Compounding Market
9. China Animal Drug Compounding Market
10. India Animal Drug Compounding Market
11. Japan Animal Drug Compounding Market
12. Australia Animal Drug Compounding Market
13. Indonesia Animal Drug Compounding Market
14. South Korea Animal Drug Compounding Market
15. Western Europe Animal Drug Compounding Market
16. UK Animal Drug Compounding Market
17. Germany Animal Drug Compounding Market
18. France Animal Drug Compounding Market
19. Italy Animal Drug Compounding Market
20. Spain Animal Drug Compounding Market
21. Eastern Europe Animal Drug Compounding Market
22. Russia Animal Drug Compounding Market
23. North America Animal Drug Compounding Market
24. USA Animal Drug Compounding Market
25. Canada Animal Drug Compounding Market
26. South America Animal Drug Compounding Market
27. Brazil Animal Drug Compounding Market
28. Middle East Animal Drug Compounding Market
29. Africa Animal Drug Compounding Market
30. Animal Drug Compounding Market Competitive Landscape and Company Profiles
31. Animal Drug Compounding Market Other Major and Innovative Companies
35. Animal Drug Compounding Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Animal Drug Compounding Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on animal drug compounding market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for animal drug compounding ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The animal drug compounding market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Animal Type: Companion Animals; Livestock Animals2) by Product: Anti-Infective Agents; Anti-inflammatory Agents; Hormones and Substitutes; CNS Agents; Other Products
3) by Route of Administration: Oral; Injectable; Topical; Other Routes of Administration
4) by Application: Veterinary Hospitals; Veterinary Clinics; Veterinary Diagnostic Centers
Subsegments:
1) by Companion Animals: Dogs; Cats; Horses; Other Small Mammals2) by Livestock Animals: Cattle; Swine; Poultry; Sheep; Goats
Key Companies Mentioned: Wedgewood Pharmacy LLC; Triangle Compounding Pharmacy Inc.; Davis Islands Pharmacy & Compounding Lab; Custom Med Compounding Pharmacy; Central Compounding Center South LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Animal Drug Compounding market report include:- Wedgewood Pharmacy LLC
- Triangle Compounding Pharmacy Inc.
- Davis Islands Pharmacy & Compounding Lab
- Custom Med Compounding Pharmacy
- Central Compounding Center South LLC
- Wellness Compounding Pharmacy of Cary LLC
- Miller's Pharmacy
- Caringbah Compounding Pharmacy Pty. Ltd.
- Smith Drug and Compounding Inc.
- Specialist Compounding Pharmacy Pte Ltd.
- Tache Pharmacy & Medical Supplies
- Hoye's Pharmacy
- Vertisis Custom Pharmacy LLC
- Smith-Caldwell Drug Store Inc.
- Sixth Avenue Medical Pharmacy
- Pharmaca Integrative Pharmacy Inc.
- Akina Animal Health
- Letco Medical LLC
- The Pet Apothecary LLC
- Vetsource Inc.
- Roadrunner Pharmacy
- Medisca Inc.
- BCP Veterinary Pharmacy
- VetRxDirect LLC
- Diamondback Drugs
- Vetcentric Pty. Ltd.
- Pet Health Pharmacy
- PetMed Express Inc.
- PetRx2Go
- South Wellness Pharmacy
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 1.79 Billion |
| Forecasted Market Value ( USD | $ 2.38 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
